QGEN vs MEDP
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 22, 2026
QGEN
MEDP
Investment Advisor Scores
MEDP
AI Analyst Insights
Detailed Metrics Comparison
| Metric | QGEN | MEDP | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 13.5318 | 31.9489 | QGEN |
| PEG Ratio | 1.1661 | 2.9349 | QGEN |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 0.3% | 17.2% | MEDP |
| Earnings Growth | 7.9% | 37.1% | MEDP |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 45.8/100 | 46.2/100 | MEDP |
| Profit Margin | 19.5% | 17.7% | QGEN |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
QGEN
MarkupPrice above SMA50, rising 50-day trend (3.7% over 20 days), RSI 74
MEDP
MarkupPrice above SMA50, rising 50-day trend (3.1% over 20 days), RSI 72
Fundamentals Snapshot
| Metric | QGEN | MEDP |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 19.1 | 34.3 |
| Trailing P/E | 24.8 | 36.5 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.2% |
| Gross Margin | 0.7% | 0.7% |
| Operating Margin | 0.3% | 0.2% |
| EPS | 1.97 | 17.03 |
| Dividend Yield | 0.01% | — |